GlassScriptPhysician profile
Sarah Gostich
NPI 1649824186
$12,472.98
in general payments reported to CMS, 2019-2025
26 companies · $1,866 in 2025
The $1,866 reported for 2025 was more than what 82% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $537 · 2021: $1,679 · 2022: $2,623 · 2023: $2,845 · 2024: $2,463 · 2025: $1,866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,487 · Travel and Lodging: $2,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,486.91 |
| Travel and Lodging | $2,687.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,951.29 | 2019-2024 | Variax, Augment Injectable, Hoffmann |
| Integra Lifesciences Corporation | $1,539.67 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medline Industries LP | $1,292.17 | 2024 | |
| Reel Surgical, INC. | $1,253.08 | 2022-2023 | |
| Paragon 28, INC. | $827.67 | 2025 | Portfolio, Monkey Rings |
| Treace Medical Concepts, INC. | $562.51 | 2021-2023 | |
| Arthrex, INC. | $480.50 | 2022-2025 | |
| Sanara Medtech INC. | $292.75 | 2023-2025 | Celleraterx, Celleraterx |
| Bone Support INC. | $249.55 | 2024 | Cerament G, Ceramentbone Void Filler |
| Linvatec Corporation | $245.73 | 2023 | Quantum, Colink 2, In2bones USA |
| US Implant Solutions, LLC | $227.53 | 2025 | |
| Kerecis Limited | $187.39 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Flower Orthopedics Coporation | $155.00 | 2021 | |
| Mimedx Group, INC. | $151.75 | 2024 | |
| Triad Life Sciences INC. | $139.64 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $137.94 | 2020-2022 | |
| Next Science LLC | $135.33 | 2023 | Surgx, Blastx, Xperience |
| Forma Medical | $133.25 | 2024 | Optimalakin |
| Smith+Nephew, INC. | $115.48 | 2021-2025 | Evos, Stravix, Renasys Go V2 Home |
| Amniox Medical, INC. | $95.56 | 2019 | |
| Biotissue Holdings INC. | $87.90 | 2021 | |
| Theramicro, INC. | $86.68 | 2025 | Stemnios, Centavisc, Tekbrace Solo |
| Trice Medical, INC. | $71.43 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.60 | 2022 | |
| Paratek Pharmaceuticals, INC. | $17.86 | 2023 | Nuzyra |
| Bioventus LLC | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Gostich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.